Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease
Jan Zuna, Lenka Hovorková, Justina Krotka, Amelie Koehrmann, Michela Bardini, Lucie Winkowska, Eva Froňková, Julia Alten, Rolf Koehler, Cornelia Eckert, Lisa Brizzolara, Marie Trková, Jan Stuchlý, Martin Zimmermann, Paola De Lorenzo, Maria Grazia Valsecchi, Valentino Conter, Jan Starý, Martin Schrappe, Andrea Biondi, Jan Trka, Markéta Žaliová, Giovanni Cazzaniga, Gunnar Cario
Topics & Concepts
Minimal residual diseaseMedicineOncologyInternal medicineMyeloid leukemiaDiseasebreakpoint cluster regionChemotherapyABLLeukemiaImmunologyTyrosine kinaseReceptorAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia Research